Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022
Revenue for the year ending December 31, 2022 is expected to be in the range of approximately $1.33 billion to $1.35 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.1 USD | +0.14% |
|
-1.34% | -33.06% |
06-04 | Evolent Health to Acquire Certain Assets From Machinify | MT |
06-04 | Evolent Health, Inc. agreed to acquire Certain assets of Machinify Inc for $32 million. | CI |
1st Jan change | Capi. | |
---|---|---|
-33.06% | 2.53B | |
-4.40% | 28.89B | |
+42.42% | 9.47B | |
-9.44% | 1.62B | |
-24.58% | 1.26B | |
-41.82% | 1B | |
+5.41% | 943M | |
-43.66% | 821M | |
-28.88% | 664M | |
-18.18% | 578M |